LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 4 of 15: End-point mean cell counts and mean normalized growth rate inhibition values for biological replicate 1. - Dataset (ID:20312)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 5.10 | 770.96 | 959 | 984 | 0.9749 | 0.8885 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 7.30 | 770.96 | 1036 | 1067 | 0.9710 | 0.8844 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 9.60 | 770.96 | 1127 | 1178 | 0.9569 | 0.8675 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 11.90 | 770.96 | 1233 | 1319 | 0.9350 | 0.8360 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 14.10 | 770.96 | 1357 | 1478 | 0.9184 | 0.8270 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 16.40 | 770.96 | 1422 | 1625 | 0.8759 | 0.7686 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 18.60 | 770.96 | 1455 | 1786 | 0.8150 | 0.6896 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 20.80 | 770.96 | 1455 | 1959 | 0.7433 | 0.6039 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 23.00 | 770.96 | 1459 | 2193 | 0.6656 | 0.5263 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 25.30 | 770.96 | 1457 | 2456 | 0.5934 | 0.4628 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 27.50 | 770.96 | 1458 | 2754 | 0.5298 | 0.4146 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 29.70 | 770.96 | 1449 | 3022 | 0.4795 | 0.3768 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 31.90 | 770.96 | 1464 | 3294 | 0.4448 | 0.3578 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 34.10 | 770.96 | 1444 | 3605 | 0.4007 | 0.3252 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 36.40 | 770.96 | 1458 | 3985 | 0.3660 | 0.3081 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 38.60 | 770.96 | 1462 | 4421 | 0.3308 | 0.2886 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 40.80 | 770.96 | 1485 | 4874 | 0.3048 | 0.2790 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 43.00 | 770.96 | 1486 | 5280 | 0.2816 | 0.2664 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 45.30 | 770.96 | 1510 | 5677 | 0.2661 | 0.2624 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 47.50 | 770.96 | 1550 | 6082 | 0.2550 | 0.2637 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 49.70 | 770.96 | 1578 | 6511 | 0.2424 | 0.2613 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 51.90 | 770.96 | 1596 | 6944 | 0.2299 | 0.2573 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 54.10 | 770.96 | 1644 | 7405 | 0.2221 | 0.2608 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 56.40 | 770.96 | 1685 | 7845 | 0.2148 | 0.2628 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 58.60 | 770.96 | 1715 | 8264 | 0.2076 | 0.2628 |